The Center for Medicare & Medicaid Service’s proposal to cut about 12% from its End-Stage-Renal-Disease treatment reimbursement program drew harsh words from the non-profit Renal Support Network.
Organization CEO Lori Hartwell called the proposal "draconian" and warned that the cuts most harms patients, especially those with limited access to dialysis care.